SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is currently rallying as investors rotate capital into AI-driven software, fueled by strong revenue growth and a new strategic partnership with Palantir that validates its enterprise marketing infrastructure. The community is heavily focused on the stock's transition from a range-bound asset to a growth leader, with many bulls highlighting successful deal momentum and long-term valuation potential while bears remain skeptical about short-term volatility and executive leadership.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is currently the subject of intense volatility and debate as retail investors and institutions clash over its lofty valuation following a high-profile IPO. Community sentiment is deeply divided between long-term believers citing Starlinks growth potential and skepticism from traders who view the recent price action as a classic over-hyped retail trap.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is trending as investors debate the sustainability of its parabolic rally, which has been fueled by an intense AI-driven memory shortage. While some traders view the stock as a bubble primed for a massive correction, others believe the structural demand for memory infrastructure justifies further upside heading into upcoming sector earnings.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is trending as investors react to the company's direct participation in recent White House quantum initiatives and the launch of its Quantum Space Initiative. The community is actively debating the company's valuation and long-term potential compared to peers, with many highlighting its government-backed contracts and upcoming Russell 3000 index inclusion as catalysts for future growth.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Tech stocks are facing a broad sell-off as a massive market crash in South Korea sparks contagion fears and increases skepticism regarding AI infrastructure spending. While traders are actively debating whether this is a temporary dip to buy or the beginning of a deeper structural unwind, community sentiment remains sharply divided between those calling for a rebound and those bracing for further downside volatility.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as investors weigh an AI-driven growth thesis against a volatile semiconductor sector, with the community actively debating whether the recent overnight selloff is a technical correction or a sign of deeper sector contagion following market weakness in Asia. While bulls argue that these dips are prime buying opportunities ahead of upcoming earnings, bears remain focused on high valuations and potential downside risks from a crowded trade.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently facing significant downward pressure and a breach of key technical support levels, sparking intense debate among community members over whether this represents a long-term accumulation opportunity or a broader structural shift. The conversation is heavily polarized, with many retail investors debating the company's valuation against its ongoing defense and commercial contract wins while short-term traders closely monitor capitulation signals.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF (TLT) is experiencing heightened volatility as investors weigh the potential for a geopolitical resolution in the Middle East against ongoing concerns about sticky inflation and Federal Reserve policy. The community remains deeply divided, with discussions centered on whether recent data suggests a bottoming for long-term yields or if the bond market remains vulnerable to further inflationary shocks.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is experiencing significant volatility driven by a mix of market-wide tech pullbacks and intense investor debate over its speculative valuation versus its long-term potential as a quantum computing leader. Community discourse is currently split between optimism surrounding new government-backed quantum initiatives and skepticism regarding the company's heavy cash burn, potential for dilution, and reliance on acquisitions.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Markets are facing a sharp sell-off driven by a combination of global tech weakness, cooling AI sector sentiment, and growing anxiety over potential hawkish pivots from the Fed. Investors are actively debating whether this is a structural correction fueled by excessive valuations or a transitory dip that presents a buying opportunity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IDYA analyst consensus revenue estimates versus $NUVL &amp; $ACLX via graph &amp; simple 5-year revenue multiple comparison. ACLX was acquired for an EV of $7.3B &amp; NUVB was $9.4B (rounded). 
 
None of the 3 have a FDA approved therapy yet though obviously NUVL &amp; ACLX had active PDUFA dates when acquired. 
 
Our simple question...if analysts believe IDYA will meaningfully outsell ACLX and, more or less, generate revenues consistent with NUVL, does this suggest IDYA&#39;s risk v reward profile is compelling? 
 
Are there any reasons IDYA&#39;s valuation as a multiple of analysts estimates won&#39;t match the 2 (assuming BLA&#39;s are submitted)? 
 
This is not investment advice. $XBI $NBI

StockTwits Web

Ideaya Biosciences Inc

Nuvalent Inc - Ordinary Shares - Class A

Arcellx Inc

SPDR S&P Biotech ETF

NASDAQ Biotechnology

 analyst consensus revenue estimates versus 

 via graph & simple 5-year revenue multiple comparison. ACLX was acquired for an EV of $7.3B & NUVB was $9.4B (rounded). 
 
None of the 3 have a FDA approved therapy yet though obviously NUVL & ACLX had active PDUFA dates when acquired. 
 
Our simple question...if analysts believe IDYA will meaningfully outsell ACLX and, more or less, generate revenues consistent with NUVL, does this suggest IDYA's risk v reward profile is compelling? 
 
Are there any reasons IDYA's valuation as a multiple of analysts estimates won't match the 2 (assuming BLA's are submitted)? 
 
This is not investment advice. 

Night Owl Biotech Research

@Night_Owl_Biotech good chart…one edit to your post…$IOVA  DOES have an FDA approved therapy for second line melanoma and already has significant revenue.  They are submitting a BLA for NSCLC that is 10x the market for melanoma and they are pushing for first line melanoma approval with endometrial and sarcoma also in the pipeline.  IMO it is SIGNIFICANTLY undervalued!

StockTwits for iOS

 good chart…one edit to your post…$IOVA  DOES have an FDA approved therapy for second line melanoma and already has significant revenue.  They are submitting a BLA for NSCLC that is 10x the market for melanoma and they are pushing for first line melanoma approval with endometrial and sarcoma also in the pipeline.  IMO it is SIGNIFICANTLY undervalued!

Adam Taylor

@TVC1  
 
I hear you. The evidence suggests TIL&#39;s profile is truly compelling. Though I thought the market for the lung cancer in question was 7X bigger, whichever it is becomes a very big number. I cannot believe analysts are a $1B in peak sales. The evidence suggests it is at least 2X higher. 
 
Thank you for the post.

  
 
I hear you. The evidence suggests TIL's profile is truly compelling. Though I thought the market for the lung cancer in question was 7X bigger, whichever it is becomes a very big number. I cannot believe analysts are a $1B in peak sales. The evidence suggests it is at least 2X higher. 
 
Thank you for the post.

@Night_Owl_Biotech Just look at IDYA price action daily. The manipulation here is easy on SWTX level after Ogsiveo 2b/3 data.

StockTwits For Android 

 Just look at IDYA price action daily. The manipulation here is easy on SWTX level after Ogsiveo 2b/3 data.